Protagenic Therapeutics Inc new (PTIX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PTIX Annual Balance Sheets →
This balance sheet overview for Protagenic Therapeutics Inc new spans from Jun 30 2025 to Jun 30 2026, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent0.00
Cash & Short-term Investments0.00
Value Added Tax Receivable, Current0.00
Inventories0.00
Other Current Assets0.00
Prepaid Expense, Current AS0.14
Total Current Assets0.71
Equipment/Property/Plant Net0.15
Intangible Assets2.08
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent0.42
Total Assets2.80
Liabilities
Accounts Payable, Current AC1.00
Accrued Liabilities, Current AC0.07
Derivative Liability, Current DE0.00
Short-term Debt0.00
Other Liabilities, Current0.00
Total Current Liabilities1.07
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Total Liabilities1.07
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock7.06
Retained Earnings / Accumulated Deficit-4.99
Accumulated Other Comprehensive Income-0.34
Other Equity0.00
Common Stockholder's Equity1.72
Total Stockholder's Equity1.72
Liabilities & Stockholder's Equity2.80
4 historic quarters locked

Sign in to unlock the full Protagenic Therapeutics Inc new balance sheet history.

About Protagenic Therapeutics Inc New Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 19, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-039221

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.